RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges
G protein-coupled receptors (GPCRs) are the major targets of existing drugs for a plethora of human diseases and dominate the pharmaceutical market. However, over 50% of the GPCRs remain undruggable. To pursue a breakthrough and overcome this situation, there is significant clinical research for dev...
Saved in:
Main Authors: | Wanjun Yuan (Author), Xiangyang Shi (Author), Leo Tsz On Lee (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemorphins Targeting G Protein-Coupled Receptors
by: Mohammed Akli Ayoub, et al.
Published: (2021) -
Advances in the molecular understanding of G protein-coupled receptors and their future therapeutic opportunities
by: Daniel N. Obot, et al.
Published: (2021) -
Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases
by: Salomé Gonçalves-Monteiro, et al.
Published: (2021) -
Sphingosine-1-Phosphate-Specific G Protein-Coupled Receptors as Novel Therapeutic Targets for Atherosclerosis
by: Yoh Takuwa, et al.
Published: (2011) -
G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis
by: Emiel P. C. van der Vorst, et al.
Published: (2019)